Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rey

Showing results (851-860 of 891) with videos related to

Pageof 90
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
Nature|April 30, 2025
A MERS-CoV-like mink coronavirus uses ACE2 as an entry receptorNingning Wang, Weiwei Ji, Houqi Jiao, et al.
Nature Immunology|December 16, 2014
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virusWanwisa Dejnirattisai, Wiyada Wongwiwat, Sunpetchuda Supasa, et al.
Elife|April 22, 2020
Multimeric single-domain antibody complexes protect against bunyavirus infectionsPaul J Wichgers Schreur, Sandra van de Water, Michiel Harmsen, et al.
Ebiomedicine|May 10, 2017
The Role of Heterotypic DENV-specific CD8<sup>+</sup>T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus InfectionLaura B Talarico, Juan P Batalle, Alana B Byrne, et al.
Nature Communications|November 21, 2025
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivoSimon Blachier, Marie-Christine Vaney, Laurine Conquet, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Journal of Biotechnology|September 2, 2003
The complete Corynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitaminsJörn Kalinowski, Brigitte Bathe, Daniela Bartels, et al.
Nature|February 16, 2022
Bat coronaviruses related to SARS-CoV-2 and infectious for human cellsSarah Temmam, Khamsing Vongphayloth, Eduard Baquero, et al.
Pageof 90

Showing results (851-860 of 891) with videos related to

Sort By:
Pageof 90
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
Nature|April 30, 2025
A MERS-CoV-like mink coronavirus uses ACE2 as an entry receptorNingning Wang, Weiwei Ji, Houqi Jiao, et al.
Nature Immunology|December 16, 2014
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virusWanwisa Dejnirattisai, Wiyada Wongwiwat, Sunpetchuda Supasa, et al.
Elife|April 22, 2020
Multimeric single-domain antibody complexes protect against bunyavirus infectionsPaul J Wichgers Schreur, Sandra van de Water, Michiel Harmsen, et al.
Ebiomedicine|May 10, 2017
The Role of Heterotypic DENV-specific CD8<sup>+</sup>T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus InfectionLaura B Talarico, Juan P Batalle, Alana B Byrne, et al.
Nature Communications|November 21, 2025
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivoSimon Blachier, Marie-Christine Vaney, Laurine Conquet, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Journal of Biotechnology|September 2, 2003
The complete Corynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitaminsJörn Kalinowski, Brigitte Bathe, Daniela Bartels, et al.
Nature|February 16, 2022
Bat coronaviruses related to SARS-CoV-2 and infectious for human cellsSarah Temmam, Khamsing Vongphayloth, Eduard Baquero, et al.
Pageof 90